These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 30506713)

  • 1. A modified staging of early and intermediate hepatocellular carcinoma based on single tumour >7 cm and multiple tumours beyond up-to-seven criteria.
    Wang YY; Zhong JH; Xu HF; Xu G; Wang LJ; Xu D; Wang HW; Wang K; Xiang BD; Mao YL; Li LQ; Xing BC
    Aliment Pharmacol Ther; 2019 Jan; 49(2):202-210. PubMed ID: 30506713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External validation of a simplified BCLC staging system for early hepatocellular carcinoma.
    Santambrogio R; Salceda J; Costa M; Kluger MD; Barabino M; Laurent A; Opocher E; Azoulay D; Cherqui D
    Eur J Surg Oncol; 2013 Aug; 39(8):850-7. PubMed ID: 23726257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection criteria for hepatic resection in intermediate-stage (BCLC stage B) multiple hepatocellular carcinoma.
    Wada H; Eguchi H; Noda T; Ogawa H; Yamada D; Tomimaru Y; Tomokuni A; Asaoka T; Kawamoto K; Gotoh K; Marubashi S; Umeshita K; Nagano H; Doki Y; Mori M
    Surgery; 2016 Nov; 160(5):1227-1235. PubMed ID: 27395761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A proposed modification for the Barcelona Clinic Liver Cancer staging system: Adding bile duct tumor thrombus status in patients with hepatocellular carcinoma.
    Lu WP; Tang HW; Yang ZY; Jiang K; Chen YL; Lu SC
    Am J Surg; 2020 Oct; 220(4):965-971. PubMed ID: 32336518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma tumour burden score to stratify prognosis after resection.
    Tsilimigras DI; Moris D; Hyer JM; Bagante F; Sahara K; Moro A; Paredes AZ; Mehta R; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Sasaki K; Rodarte AI; Aucejo FN; Pawlik TM
    Br J Surg; 2020 Jun; 107(7):854-864. PubMed ID: 32057105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary liver resection for patients with cirrhosis and hepatocellular carcinoma: the role of surgery in BCLC early (A) and intermediate stages (B).
    Bell R; Pandanaboyana S; Lodge JPA; Prasad KR; Jones R; Hidalgo E
    Langenbecks Arch Surg; 2017 Jun; 402(4):575-583. PubMed ID: 27456677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic Resection Provides Survival Benefit for Selected Intermediate-Stage (BCLC-B) Hepatocellular Carcinoma Patients.
    Zhaohui Z; Shunli S; Bin C; Shaoqiang L; Yunpeng H; Ming K; Lijian L; Gang PB
    Cancer Res Treat; 2019 Jan; 51(1):65-72. PubMed ID: 29510616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined measurements of tumor number and size helps estimate the outcome of resection of Barcelona clinic liver cancer stage B hepatocellular carcinoma.
    Wang X; Wang Z; Wu L
    BMC Surg; 2016 Apr; 16():22. PubMed ID: 27094483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
    Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
    World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver resection of hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guideline recommendations: Results from a high-volume liver surgery center in East Asia.
    Liu YW; Yong CC; Lin CC; Wang CC; Chen CL; Cheng YF; Wang JH; Yen YH; Chen CH
    J Surg Oncol; 2020 Dec; 122(8):1587-1594. PubMed ID: 32815189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification.
    Tsilimigras DI; Bagante F; Sahara K; Moris D; Hyer JM; Wu L; Ratti F; Marques HP; Soubrane O; Paredes AZ; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
    Ann Surg Oncol; 2019 Oct; 26(11):3693-3700. PubMed ID: 31267302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment and prognosis study of spontaneous rupture hemorrhage in hepatocellular carcinoma: Recommendations for adding the A1 stage to the BCLC staging system.
    Ni Q; Jia H; Zhang Y; Lu J; Chang H
    Cancer Med; 2024 May; 13(10):e6952. PubMed ID: 38752672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical and oncological outcomes of hepatic resection for BCLC-B hepatocellular carcinoma: a retrospective multicenter analysis among 474 consecutive cases.
    Di Sandro S; Centonze L; Pinotti E; Lauterio A; De Carlis R; Romano F; Gianotti L; De Carlis L;
    Updates Surg; 2019 Jun; 71(2):285-293. PubMed ID: 30941704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival benefit of hepatic resection for hepatocellular carcinoma beyond the Barcelona Clinic Liver Cancer classification.
    Furukawa K; Shiba H; Horiuchi T; Shirai Y; Haruki K; Fujiwara Y; Sakamoto T; Gocho T; Yanaga K
    J Hepatobiliary Pancreat Sci; 2017 Apr; 24(4):199-205. PubMed ID: 28160422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence Patterns and Outcomes after Resection of Hepatocellular Carcinoma within and beyond the Barcelona Clinic Liver Cancer Criteria.
    Tsilimigras DI; Bagante F; Moris D; Hyer JM; Sahara K; Paredes AZ; Mehta R; Ratti F; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
    Ann Surg Oncol; 2020 Jul; 27(7):2321-2331. PubMed ID: 32285278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative blood transfusion has distinct postsurgical oncologic impact on patients with different stage of hepatocellular carcinoma.
    Chen GX; Qi CY; Hu WJ; Wang XH; Hua YP; Kuang M; Peng BG; Li SQ
    BMC Cancer; 2020 May; 20(1):487. PubMed ID: 32471389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nomogram integrating hepatic reserve and tumor characteristics for hepatocellular carcinoma following curative liver resection.
    Cai BB; Shi KQ; Li P; Chen BC; Shi L; Johnson PJ; Lai P; Toyoda H; Zhou MT
    Clin Chim Acta; 2018 Oct; 485():187-194. PubMed ID: 29908940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilizing Machine Learning for Pre- and Postoperative Assessment of Patients Undergoing Resection for BCLC-0, A and B Hepatocellular Carcinoma: Implications for Resection Beyond the BCLC Guidelines.
    Tsilimigras DI; Mehta R; Moris D; Sahara K; Bagante F; Paredes AZ; Farooq A; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Grigorie R; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
    Ann Surg Oncol; 2020 Mar; 27(3):866-874. PubMed ID: 31696396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
    Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I
    World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Better prognosis of hepatic resection combined with antiviral therapy for HBV-related hepatocellular carcinoma with BCLC Stage B/C.
    Wei Q; Tian H; Luo HX; Zhang YC; Deng YN; Yao J; Li H; Chen GH; Yang Y
    Asian J Surg; 2017 Nov; 40(6):453-462. PubMed ID: 27321176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.